Helius Medical Technologies Inc (NASDAQ:HSDT)’s traded shares stood at 1.08 million during the last session, with the company’s beta value hitting 1.45. At the close of trading, the stock’s price was $1.02, to imply an increase of 6.25% or $0.06 in intraday trading. The HSDT share’s 52-week high remains $9.50, putting it -831.37% down since that peak but still an impressive 63.73% since price per share fell to its 52-week low of $0.37. The company has a valuation of $4.04M, with an average of 12.78 million shares in intraday trading volume over the past 10 days and average of 2.32 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Helius Medical Technologies Inc (HSDT), translating to a mean rating of 1.00. Of 3 analyst(s) looking at the stock, 0 analyst(s) give HSDT a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 3 recommend it as a Buy.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Helius Medical Technologies Inc (NASDAQ:HSDT) trade information
After registering a 6.25% upside in the last session, Helius Medical Technologies Inc (HSDT) has traded red over the past five days. The 5-day price performance for the stock is 107.13%, and 114.81% over 30 days. With these gigs, the year-to-date price performance is -87.89%. Short interest in Helius Medical Technologies Inc (NASDAQ:HSDT) saw shorts transact 0.23 million shares and set a 0.34 days time to cover.
HSDT Dividends
Helius Medical Technologies Inc has its next earnings report out in January. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Helius Medical Technologies Inc (NASDAQ:HSDT)’s Major holders
Helius Medical Technologies Inc insiders hold 0.53% of total outstanding shares, with institutional holders owning 5.87% of the shares at 5.90% float percentage. In total, 5.87% institutions holds shares in the company.
We also have Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Helius Medical Technologies Inc (HSDT) shares. Going by data provided on Oct 31, 2024 , Fidelity Extended Market Index Fund holds roughly 16.64 shares. This is just over 0.45% of the total shares, with a market valuation of $16970.0. Data from the same date shows that the other fund manager holds a little less at 12.6, or 0.34% of the shares, all valued at about 12849.0.
